MKI67 and neoplasm: p38 MAPKhigh/ERKlow phenotype is now widely used as a marker of dormant cells and the proliferation marker MKI67 and the cyclin-dependent kinase (CDK) inhibitor P27 are often used to label and identify dormant tumor cells18, 34.